Genome Up
1 known investors
Find your way into Genome Up
Sign up to see every warm intro you have to Genome Up
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genome Up team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Omzey (formerly GenomeUp) develops JuliaOmix, a diagnostic suite designed to accelerate the diagnosis of rare diseases using omics sciences. The company serves clinicians, researchers, and patients working in rare disease diagnostics and precision medicine.
Investors · 1
Frequently asked questions
- What does Genome Up do?
- Omzey (formerly GenomeUp) develops JuliaOmix, a diagnostic suite designed to accelerate the diagnosis of rare diseases using omics sciences. The company serves clinicians, researchers, and patients working in rare disease diagnostics and precision medicine.
- Who are Genome Up's investors?
- Genome Up's investors include Lumen Ventures.
- Where is Genome Up headquartered?
- Genome Up is headquartered in Unknown, IT.